article thumbnail

Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research

Vial

In this article, we will define preclinical and clinical CROs, as well as highlight the unique needs and challenges of these organizations in their respective stages of drug research. What is a Pre-Clinical CRO? The global preclinical CRO market was estimated to be valued at US$5.7 billion in 2022 and is projected to reach US$10.2

article thumbnail

New podcast: Innovate to reinvent the future of drug discovery

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, “ Innovating now to reinvent the future of drug discovery”. They are called “ Predictive biomarkers in the age of spatial biology ”, “ Exploiting the microbiome to drive nature – inspired innovation ”, and “ Animal research: reinventing the norm ”.

Drugs 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug discovery hotspots: What is the secret to Switzerland’s success? (part 2)

Drug Discovery World

The AI revolution Artificial intelligence (AI) is becoming an integral tool in drug discovery, and Swiss researchers have been some of the first to capitalise on and progress this new resource. Swiss companies are also applying AI beyond preclinical drug discovery, to clinical trials and upskilling staff.

Drugs 130
article thumbnail

Origins of the Lab Mouse

Codon

” It’s an uncharitable take, but when drugs fail as often as they do despite animal testing, it’s not hard to see the JAX mice as a metaphor for a biomedical enterprise cloistered away from the real world. In cancer, the focus of Little’s ambitions, mouse models leave much to be desired.